Viewing Study NCT00226759


Ignite Creation Date: 2025-12-24 @ 2:56 PM
Ignite Modification Date: 2025-12-26 @ 4:18 PM
Study NCT ID: NCT00226759
Status: COMPLETED
Last Update Posted: 2012-10-12
First Post: 2005-09-26
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Efficacy and Safety of OMS103HP in Patients Undergoing Allograft Anterior Cruciate Ligament (ACL) Reconstruction
Sponsor: Omeros Corporation
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module